{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:43:39Z","timestamp":1740149019679,"version":"3.37.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82101146","82060183"],"award-info":[{"award-number":["82101146","82060183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005090","name":"The Beijing Nova Program","doi-asserted-by":"crossref","award":["Z211100002121052"],"award-info":[{"award-number":["Z211100002121052"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Leading talents of innovative projects in Beijing Economic and Technological Development Zone"},{"name":"The Priming Scientific Research Foundation for the Junior Research in Beijing Tongren Hospital Capital Medical University","award":["2017-YJJ-ZZL-009 and 2018-YJJ-ZZL-046"],"award-info":[{"award-number":["2017-YJJ-ZZL-009 and 2018-YJJ-ZZL-046"]}]},{"name":"Beijing Tongren Hospital Top Talent Training Program"},{"name":"The key research and development project of Ningxia Hui Autonomous Region","award":["2020BEG03047"],"award-info":[{"award-number":["2020BEG03047"]}]},{"name":"The training project of the scientific innovation commanding talented person in Ningxia Hui Autonomous Region","award":["KJT2020013"],"award-info":[{"award-number":["KJT2020013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The genotype characteristics and their associated clinical phenotypes in patients with aniridia were analyzed to explore pathogenic variants using whole-exome sequencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One patient with aniridia was enrolled at the Beijing Tongren Hospital. Comprehensive ophthalmic and general examinations were performed on the patient. DNA was extracted from the patient, and whole-exome sequencing was performed to identify the causative variant. The pathogenicity of the variant was predicted using in silico analysis and evaluated according to American College of Medical Genetics and Genomics guidelines. Relationships between genetic variants and clinical features were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In addition to the classical aniridia phenotype showing complete iris aplasia, foveal hypoplasia, and ectopic lentis, the patient also exhibited spontaneous reattachment rhegmatogenous retinal detachment (SRRRD). Whole-exome sequencing identified a novel heterozygous variant, exon8:c.640_646del:p.R214Pfs*28.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study broadens the range of genetic variants described in aniridia and presents an aniridia patient with SRRRD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01620-w","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:02:22Z","timestamp":1691136142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel PAX6 variant as the cause of aniridia in a Chinese patient with SRRRD"],"prefix":"10.1186","volume":"16","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Ning","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"1620_CR1","first-page":"226","volume":"26","author":"B You","year":"2020","unstructured":"You B, Zhang X, Xu K, Xie Y, Ye H, Li Y. Mutation spectrum of PAX6 and clinical findings in 95 chinese patients with aniridia. Mol Vis. 2020;26:226\u201334.","journal-title":"Mol Vis"},{"key":"1620_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12886-021-02120-0","volume":"21","author":"T Qian","year":"2021","unstructured":"Qian T, Chen C, Li C, Gong Q, Liu K, Wang G, Schrauwen I, Xu X. A novel 4.25\u00a0kb heterozygous deletion in PAX6 in a chinese Han family with congenital aniridia combined with cataract and nystagmus. BMC Ophthalmol. 2021;21:353.","journal-title":"BMC Ophthalmol"},{"unstructured":"Moosajee M, Hingorani M, Moore AT, PAX6-related aniridia. 2003 May 20 [updated 2018 Oct 18]. In: Adam MP, Everman DB, Mirzaa GM, editors. Gene Reviews. Seattle (WA): University of Washington, Seattle; 1993\u20132022.","key":"1620_CR3"},{"issue":"5","key":"1620_CR4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ICU.0000000000000405","volume":"28","author":"HT Lim","year":"2017","unstructured":"Lim HT, Kim DH, Kim H. PAX6 aniridia syndrome: clinics, genetics, and therapeutics. Curr Opin Ophthalmol. 2017;28(5):436\u201347.","journal-title":"Curr Opin Ophthalmol"},{"key":"1620_CR5","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1167\/iovs.08-2827","volume":"50","author":"M Hingorani","year":"2009","unstructured":"Hingorani M, Williamson KA, Moore AT, van Heyningen V. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Invest Ophthalmol Visual Sci. 2009;50:2581\u201390.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1620_CR6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1212\/01.WNL.0000118298.81140.62","volume":"62","author":"PJ Thompson","year":"2004","unstructured":"Thompson PJ, Mitchell TN, Free SL, et al. Cognitive functioning in humans with mutation of the PAX6 gene. Neurology. 2004;62:1216\u20138.","journal-title":"Neurology"},{"key":"1620_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ydbio.2004.01.040","volume":"269","author":"R Ashery-Padan","year":"2004","unstructured":"Ashery-Padan R, Zhou X, Marquardt T, et al. Conditional inactivation of PAX6 in the pancreas causes early onset of diabetes. Dev Biol. 2004;269:479\u201388.","journal-title":"Dev Biol"},{"key":"1620_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1464-5491.2005.01469.x","volume":"22","author":"M Nishi","year":"2005","unstructured":"Nishi M, Sasahara M, Shono T, et al. A case of novel de novo paired box gene 6 (PAX6) mutation with early-onset diabetes mellitus and aniridia. Diabet Med. 2005;22:641\u20134.","journal-title":"Diabet Med"},{"issue":"5","key":"1620_CR9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng0892-328","volume":"1","author":"T Jordan","year":"1992","unstructured":"Jordan T, Hanson I, Zaletayez D, Hodgson S, Prosser J, Seawright A, Hastie N. Heyningen van V. The human PAX6 gene is mutated in two patients with aniridia. Nat Genet. 1992;1(5):328\u201332.","journal-title":"Nat Genet"},{"issue":"3","key":"1620_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.joco.2017.12.006","volume":"30","author":"A Torkashvand","year":"2018","unstructured":"Torkashvand A, Mohebbi M, Hashemi H. A novel PAX6 nonsense mutation identified in an iranian family with various eye anomalies. J Curr Ophthalmol. 2018;30(3):234\u20138.","journal-title":"J Curr Ophthalmol"},{"issue":"2","key":"1620_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/13816810.2015.1005318","volume":"36","author":"C Yahalom","year":"2015","unstructured":"Yahalom C, Sharon D, Dalia E, Simhon SB, Shemesh E, Blumenfeld A. Combined occurrence of autosomal dominant Aniridia and autosomal recessive albinism in several members of a family. Ophthalmic Genet. 2015;36(2):175\u20139.","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"1620_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s004390100529","volume":"109","author":"K Gr\u00f8nskov","year":"2001","unstructured":"Gr\u00f8nskov K, Olsen JH, Sand A, Pedersen W, Carlsen N, Bak Jylling AM, et al. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet. 2001;109(1):11\u20138.","journal-title":"Hum Genet"},{"issue":"1","key":"1620_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13039-015-0110-2","volume":"8","author":"P Hu","year":"2015","unstructured":"Hu P, Meng L, Ma D, Qiao F, Wang Y, Zhou J, et al. A novel 11p13 microdeletion encompassing PAX6 in a chinese Han family with aniridia, ptosis and mental retardation. Mol Cytogenet. 2015;8(1):3.","journal-title":"Mol Cytogenet"},{"issue":"5","key":"1620_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ajmg.a.32209","volume":"146a","author":"DO Robinson","year":"2008","unstructured":"Robinson DO, Howarth RJ, Williamson KA, van Heyningen V, Beal SJ, Crolla JA. Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia. Am J Med Genet Part A. 2008;146a(5):558\u201369.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"1620_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/13816810.2011.615076","volume":"33","author":"A Wawrocka","year":"2012","unstructured":"Wawrocka A, Budny B, Debicki S, Jamsheer A, Sowinska A, Krawczynski MR. PAX6 3\u2019 deletion in a family with aniridia. Ophthalmic Genet. 2012;33(1):44\u20138.","journal-title":"Ophthalmic Genet"},{"key":"1620_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cge.13019","volume":"92","author":"TA Vasilyeva","year":"2017","unstructured":"Vasilyeva TA, Voskresenskaya AA, K\u00e4smann-Kellner B, Khlebnikova OV, Pozdeyeva NA, Bayazutdinova GM, Kutsev SI, Ginter EK, Semina EV, Marakhonov AV, Zinchenko RA. Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations. Clin Genet. 2017;92:639\u201344.","journal-title":"Clin Genet"},{"key":"1620_CR17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/cge.12708","volume":"89","author":"AM Bobilev","year":"2016","unstructured":"Bobilev AM, McDougal ME, Taylor WL, et al. Assessment of PAX6 alleles in 66 families with aniridia. Clin Genet. 2016;89:669\u2013667.","journal-title":"Clin Genet"},{"issue":"22","key":"1620_CR18","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","volume":"16","author":"F Corpet","year":"1988","unstructured":"Corpet F. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res. 1988;16(22):10881\u201390.","journal-title":"Nucl Acids Res"},{"issue":"S1","key":"1620_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oftal.2020.11.025","volume":"96","author":"P Casas-Llera","year":"2021","unstructured":"Casas-Llera P, Ruiz-Casas D, Ali\u00f3 JL. Macular involvement in congenital aniridia. Arch Soc Esp Ofthalmol (Engl Ed). 2021;96(S1):60\u20137.","journal-title":"Arch Soc Esp Ofthalmol (Engl Ed)"},{"key":"1620_CR20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00439-018-1940-x","volume":"137","author":"J Plaisanci\u00e8","year":"2018","unstructured":"Plaisanci\u00e8 J, Tarilonte M, Ramos P, Jeanton-Scaramouche C, Gaston V, Dollfus H, et al. Implication of non-coding PAX6 mutations in aniridia. Hum Genet. 2018;137:831\u201346.","journal-title":"Hum Genet"},{"key":"1620_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2016.04.017","volume":"156","author":"A Cvekl","year":"2017","unstructured":"Cvekl A, Callaerts P. PAX6: 25th anniversary and more to learn. Exp Eye Res. 2017;156:10\u201321.","journal-title":"Exp Eye Res"},{"key":"1620_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.preteyeres.2012.04.002","volume":"31","author":"O Shaham","year":"2012","unstructured":"Shaham O, Menuchin Y, Farhy C, Ashery-Padan R. PAX6: a multilevel regulator of ocular development. Prog Retin Eye Res. 2012;31:351\u201376.","journal-title":"Prog Retin Eye Res"},{"key":"1620_CR23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/humu.22907","volume":"36","author":"X Zhang","year":"2015","unstructured":"Zhang X, Qin G, Chen G, et al. Variants in TRIMM44 cause aniridia by impairing PAX6 expression. Hum Mutat. 2015;36:1164\u20137.","journal-title":"Hum Mutat"},{"key":"1620_CR24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ydbio.2006.08.060","volume":"299","author":"DA Kleinjan","year":"2006","unstructured":"Kleinjan DA, Seawright A, Mella S, et al. Long-range downstream enhancers are essential for PAX6 expression. Dev Biol. 2006;299:563\u201381.","journal-title":"Dev Biol"},{"issue":"S1","key":"1620_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oftal.2021.02.002","volume":"96","author":"F Blanco-Kelly","year":"2021","unstructured":"Blanco-Kelly F, Tarilonte M, Villamar M, Dami\u00e1n A, Tamayo A, Moreno-Pelayo MA, Ayuso C, Cort\u00f3n M. Genetics and epidemiology of aniridia: updated guidelines for genetic study. Arch Soc Esp Oftalmol. 2021;96(S1):4\u201314.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"1620_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fgene.2018.00479","volume":"9","author":"M Tarilonte","year":"2018","unstructured":"Tarilonte M, Morin M, Ramos P, Galdos M, Blanco-Kelly F, Villaverde C, et al. Parental mosaicism in PAX6 causes intra-familial variability: implications for genetic counseling of congenital aniridia and microphthalmia. Front Genet. 2018;9:479.","journal-title":"Front Genet"},{"key":"1620_CR27","first-page":"261","volume":"24","author":"E Souzeau","year":"2018","unstructured":"Souzeau E, Rudkin AK, Dubowsky A, Casson RJ, Muecke JS, Mancel E, et al. PAX6 molecular analysis and genotype-phenotype correlations in families with aniridia form Australasia and Southeast Asia. Mol Vis. 2018;24:261\u201373.","journal-title":"Mol Vis"},{"key":"1620_CR28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41431-018-0288-y","volume":"27","author":"AY Filatova","year":"2019","unstructured":"Filatova AY, Vasilyeva TA, Marakhonov AV, Voskresenskaya AA, Zinchenko RA, Skoblov MY. Functional reassessment of PAX6 single nucleotide variants by in vitro splicing assay. Eur J Hum Genet. 2019;27:488\u201393.","journal-title":"Eur J Hum Genet"},{"key":"1620_CR29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41436-019-0685-9","volume":"22","author":"KA Williamson","year":"2020","unstructured":"Williamson KA, Hall HN, Owen LJ, Livesey BJ, Hanson IM, Adams GGW, et al. Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA-protein interaction. Genet Med. 2020;22:598\u2013609.","journal-title":"Genet Med"},{"issue":"4","key":"1620_CR30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmedgenet-2019-106172","volume":"58","author":"TA Vasilyeva","year":"2021","unstructured":"Vasilyeva TA, Marakhonov AV, Voskresenskaya AA, Kadyshev VV, K\u00e4smann-Kellner B, Sukhanova NV, Katargina LA, Kutsev SI, Zinchenko RA. Analysis of genotype-phenotype correlations in PAX6-associated aniridia. J Med Genet. 2021;58(4):270\u20134.","journal-title":"J Med Genet"},{"key":"1620_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ophtha.2019.09.034","volume":"127","author":"N Lagali","year":"2020","unstructured":"Lagali N, Wowra B, Fries FN, Latta L, Moslemani K, Utheim TP, et al. PAX6 mutational status determines aniridia-associated keratopathy phenotype. Ophthalmology. 2020;127:273\u20135.","journal-title":"Ophthalmology"},{"key":"1620_CR32","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1093\/hmg\/ddz168","volume":"28","author":"AV Marakhonov","year":"2019","unstructured":"Marakhonov AV, Vasilyeva TA, Voskresenskaya AA, Sukhanova NV, Kadyshev VV, Kutsev SI, et al. LMO2 gene deletions significantly worsen the prognosis of Wilms\u2019tumor development in patients with WAGR syndrome. Hum Mol Genet. 2019;28:3323\u20136.","journal-title":"Hum Mol Genet"},{"key":"1620_CR33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.61.5.14","volume":"61","author":"HR Pedersen","year":"2020","unstructured":"Pedersen HR, Baraas RC, Landsend ECS, Utheim \u00d8A, Utheim TP, Gilson SJ, et al. PAX6 genotypic and retinal phenotypic characterization in congenital aniridia. Invest Ophthalmol Vis Sci. 2020;61:14.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1620_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s10038-020-00829-2","volume":"66","author":"J Lee","year":"2021","unstructured":"Lee J, Suh Y, Jeong H, Kim GH, Byeon SH, Han J, et al. Aberrant expression of PAX6 gene associated with classical aniridia: identification and functional characterization of novel noncoding mutations. J Hum Genet. 2021;66:333\u20138.","journal-title":"J Hum Genet"},{"issue":"6","key":"1620_CR35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.survophthal.2021.02.011","volume":"66","author":"ECS Landsend","year":"2021","unstructured":"Landsend ECS, Lagali N, Utheim TP. Congenital aniridia-A comprehensive review of clinical features and therapeutic approaches. Surv Ophthalmol. 2021;66(6):1031\u201350.","journal-title":"Surv Ophthalmol"},{"key":"1620_CR36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13353-017-0426-1","volume":"59","author":"A Wawrocka","year":"2018","unstructured":"Wawrocka A, Krawczynski MR. The genetics of aniridia-simple things become complicated. J Appl Genet. 2018;59:151\u20139.","journal-title":"J Appl Genet"},{"key":"1620_CR37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13353-013-0154-0","volume":"54","author":"A Wawrocka","year":"2013","unstructured":"Wawrocka A, Sikora A, Kuszel L, Krawczynski MR. 11p13 deletions can be more frequent than the PAX6 gene point mutations in polish patients with aniridia. J Appl Genet. 2013;54:345\u201351.","journal-title":"J Appl Genet"},{"issue":"6","key":"1620_CR38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1203\/01.PDR.0000096455.00657.98","volume":"54","author":"IM Hanson","year":"2003","unstructured":"Hanson IM. PAX6 and congenital eye malformations. Pediatr Res. 2003;54(6):791\u20136.","journal-title":"Pediatr Res"},{"key":"1620_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2156-6-27","volume":"6","author":"I Tzoulaki","year":"2005","unstructured":"Tzoulaki I, White IM, Hanson IM. PAX6 mutations: genotype-phenotype correlations. BMC Genet. 2005;6:1\u201312.","journal-title":"BMC Genet"},{"key":"1620_CR40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ceb.2005.04.005","volume":"17","author":"E Conti","year":"2005","unstructured":"Conti E, Izaurralde E. Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr Opin Cell Biol. 2005;17:316\u201325.","journal-title":"Curr Opin Cell Biol"},{"key":"1620_CR41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ng1322","volume":"36","author":"K Inoue","year":"2004","unstructured":"Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet. 2004;36:361\u20139.","journal-title":"Nat Genet"},{"key":"1620_CR42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s004390100598","volume":"109","author":"TP Kerr","year":"2001","unstructured":"Kerr TP, Sewry CA, Robb SA, Roberts RG. Long mutant dystrophins and variable phenotypes: evasion of nonsense mediated decay? Hum Genet. 2001;109:402\u20137.","journal-title":"Hum Genet"},{"key":"1620_CR43","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1038\/hgv.2015.52","volume":"3","author":"T Yokoi","year":"2016","unstructured":"Yokoi T, Nishina S, Fukami M, Ogata T, Hosono K, Hotta Y, et al. Genotype-phenotype correlation of PAX6 gene mutations in aniridia. Hum Genome Variation. 2016;3:15052.","journal-title":"Hum Genome Variation"},{"key":"1620_CR44","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ophtha.2011.12.010","volume":"119","author":"HT Lim","year":"2012","unstructured":"Lim HT, Seo EJ, Kim GH, et al. Comparison between aniridia with and without PAX6 mutations: clinical and molecular analysis in 14 korean patients with aniridia. Ophthalmology. 2012;119:1258\u201364.","journal-title":"Ophthalmology"},{"key":"1620_CR45","first-page":"1305","volume":"17","author":"S Aggarwal","year":"2011","unstructured":"Aggarwal S, Jinda W, Limwongse C, et al. Run-on mutation in the PAX6 gene and chorioretinal degeneration in autosomal dominant aniridia. Mol Vis. 2011;17:1305\u20139.","journal-title":"Mol Vis"},{"key":"1620_CR46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0004.2010.01372.x","volume":"77","author":"H Kokotas","year":"2010","unstructured":"Kokotas H, Petersen MB. Clinical and molecular aspects of aniridia. Clin Genet. 2010;77:409\u201320.","journal-title":"Clin Genet"},{"key":"1620_CR47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/344396","volume":"71","author":"JA Crolla","year":"2002","unstructured":"Crolla JA, van Heyningen V. Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia. Am J Hum Genet. 2002;71:1138\u201349.","journal-title":"Am J Hum Genet"},{"key":"1620_CR48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cas.12910","volume":"107","author":"C Deng","year":"2016","unstructured":"Deng C, Dai R, li X, Liu F. Genetic variation frequencies in Wilms\u2019 tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107:690\u20139.","journal-title":"Cancer Sci"},{"key":"1620_CR49","doi-asserted-by":"crossref","first-page":"e0172363","DOI":"10.1371\/journal.pone.0172363","volume":"12","author":"F Blanco-Kelly","year":"2017","unstructured":"Blanco-Kelly F, Palomares M, Vallesp\u00edn E, et al. Improving molecular diagnosis of aniridia and WARG syndrome using customized targeted array-based CGH. PLoS ONE. 2017;12:e0172363.","journal-title":"PLoS ONE"},{"key":"1620_CR50","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajhg.2013.10.028","volume":"93","author":"S Bhatia","year":"2013","unstructured":"Bhatia S, Bengani H, Fish M, et al. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. Am J Hum Genet. 2013;93:1126\u201334.","journal-title":"Am J Hum Genet"},{"key":"1620_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/eye.1995.52","volume":"9","author":"JG Dowler","year":"1995","unstructured":"Dowler JG, Lyons CJ, Cooling RJ. Retinal detachment and giant retinal tears in aniridia. Eye. 1995;9:268\u201370.","journal-title":"Eye"},{"key":"1620_CR52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00006982-198101030-00016","volume":"1","author":"HL Cantrill","year":"1981","unstructured":"Cantrill HL. Spontaneous retinal reattachment. Retina. 1981;1:216\u20139.","journal-title":"Retina"},{"issue":"2","key":"1620_CR53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3341\/kjo.2012.26.2.135","volume":"26","author":"SE Chung","year":"2012","unstructured":"Chung SE, Kang SW, Yi Ch. A developmental mechanism of spontaneous reattachment in rhegmatogenous retinal detachment. Korean J Ophthalmol. 2012;26(2):135\u20138.","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"1620_CR54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-9394(14)76125-2","volume":"97","author":"E de Juan Jr","year":"1984","unstructured":"de Juan E Jr, Machemer R. Spontaneous reattachment of the retina despite proliferative vitreoretinopathy. Am J Ophthalmol. 1984;97(4):428\u201333.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"1620_CR55","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1007\/s00417-021-05304-y","volume":"259","author":"JH Kim","year":"2021","unstructured":"Kim JH, Kim JW, Kim CG. Characteristics of spontaneous reattachment of rhegmatogenous retinal detachment: optical coherence tomography features and follow-up outcomes. Graefes Arch Clin Exp Ophthalmol. 2021;259(12):3703\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1620_CR56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3928\/23258160-20150422-16","volume":"46","author":"A Mercanti","year":"2015","unstructured":"Mercanti A, Renna A, Prosperi R, Lanzetta P. An unusual and spontaneous resolution of a total rhegmatogenous retinal detachment. Ophthalmic Surg Lasers Imaging Retina. 2015;46:489\u201392.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"1620_CR57","first-page":"327","volume":"9","author":"L Orazbekov","year":"2021","unstructured":"Orazbekov L, Zhanbolat K, Ruslanuly K. Cases of spontaneous reattachment of rhegmatogenous retinal detachment. Oxf Med Case Rep. 2021;9:327\u20139.","journal-title":"Oxf Med Case Rep"},{"key":"1620_CR58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ophtha.2006.05.080","volume":"114","author":"HY Cho","year":"2017","unstructured":"Cho HY, Chung SE, Kim JI, Park KH, Kim SK, Kang SW. Spontaneous reattachment of rhegmatogenous retinal detachment. Ophthalmology. 2017;114:581\u20136.","journal-title":"Ophthalmology"},{"key":"1620_CR59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.preteyeres.2009.07.001","volume":"28","author":"A Bringmann","year":"2009","unstructured":"Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, et al. Cellular signaling and factors involved in M\u00fcller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res. 2009;28:423\u201351.","journal-title":"Prog Retin Eye Res"},{"key":"1620_CR60","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1167\/iovs.18-24489","volume":"59","author":"L Kiang","year":"2018","unstructured":"Kiang L, Ross BX, Yao J, Shanmugam S, Andrews CA, Hansen S, et al. Vitreous cytokine expression and a murine model suggest a key role of microglia in the inflammatory response to retinal detachment. Invest Ophthalmol Vis Sci. 2018;59:3767\u201378.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1620_CR61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10384-009-0746-8","volume":"54","author":"Y Hama","year":"2010","unstructured":"Hama Y, Hirakata A, Tomita K, Inoue M. Retinal detachment with giant oral dialysis in an eye with congenital aniridia. Jpn J Ophthalmol. 2010;54(1):105\u20137.","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"1620_CR62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/13816810.2019.1597374","volume":"40","author":"M Mirrahimi","year":"2019","unstructured":"Mirrahimi M, Sabbaghi H, Ahmadieh H, Jahanmard M, Hassanpout K, Suri F. A novel PAX6 mutation causes congenital aniridia with or without retinal detachment. Ophthalmic Genet. 2019;40(2):146\u20139.","journal-title":"Ophthalmic Genet"},{"key":"1620_CR63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000308711","volume":"176","author":"SR Andersen","year":"1977","unstructured":"Andersen SR, Geertinger P, Larsen HW, Mikkelsen M, Parving A, Vestermark S, et al. Aniridia, cataract and gonadoblastoma in a mentally retarded girl with deletion of chromosome II. A clinicopathological case report. Ophthalmologica. 1977;176:171\u20137.","journal-title":"Ophthalmologica"},{"key":"1620_CR64","first-page":"311","volume":"68","author":"DO Jeseberg","year":"1962","unstructured":"Jeseberg DO. Aniridia with retinal lipid deposits. Arch Ophthalmol. 1962;68:311\u201336.","journal-title":"Arch Ophthalmol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01620-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01620-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01620-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:30:48Z","timestamp":1700285448000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01620-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01620-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patients for participation in this study and to publish the study findings. The consent form signed by the patients has been explained in detail by the researchers, and he has no questions about the terms. Ethical aspects of the studies and procedures related to clinical examination, human sample collection and genetic analysis were approved by the Medical Ethics Committee of the Beijing Tongren Hospital. All methods were performed in accordance with the relevant guidelines and regulations of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The purpose of the study and its importance to patients and scientific community was explained to the affected individual by the clinicians. Informed consent was obtained from the patient to publish study finding and to publish the images of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author reports no conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}